SNP

Gene

Risk allele

ARIC

MESA

Pooledb

OR (95% CI)

P-value

OR (95% CI)

p-value

OR

P-value

rs10923931

NOTCH2
ADAM30

T

1.43 (1.30-1.57)

2.1×10-14

1.35 (1.16-1.57)

1.32×10-4

1.41 (1.30-1.52)

1.54×10-17

rs780094

GCKR
TMEM195

C

1.33 (1.22-1.44)

2.5×10-11

1.30 (1.14-1.47)

5.40×10-5

1.32 (1.23-1.41)

6.63×10-15

rs1801282

PPARG

C

1.53 (1.32-1.77)

1.48×10-8

1.53 (1.19-1.96)

9.66×10-4

1.53 (1.35-1.74)

5.56×10-11

rs1470579

IGF2BP2

G

1.50 (1.39-1.61)

3.27×10-28

1.24 (1.11-1.38)

1.95×10-4

1.37 (1.13-1.65)

1.2×10-3

rs10946398

CDKAL1

G

1.34 (1.24-1.44)

7.43×10-14

1.44 (1.28-1.62)

1.03×10-9

1.37 (1.28-1.47)

3.28×10-18

rs7756992

CDKAL1

C

1.42 (1.32-1.53)

7.98×10-20

1.41 (1.25-1.58)

9.14×10-9

1.42 (1.33-1.51)

4.98×10-27

rs864745

JAZF1

T

1.31 (1.22-1.42)

5.56×10-12

1.29 (1.14-1.46)

4.19×10-8

1.31 (1.22-1.40)

1.07×10-15

rs564398

CDKN2B

A

1.46 (1.34-1.59)

4.37×10-19

1.38 (1.20-1.59)

9.3×10-6

1.44 (1.34-1.55)

2.54×10-23

rs7901695

TCF7L2

C

1.45 (1.34-1.57)

1.44×10-20

1.34 (1.19-1.52)

1.36×10-6

1.42 (1.32-1.51)

1.27×10-24

rs1495377

NR

G

1.25 (1.16-1.35)

1.27×10-08

1.37 (1.21-1.56)

5.23×10-7

1.29 (1.18-1.41)

1.04×10-8

rs11634397

ZFAND6

T

1.32 (1.22-1.42)

1.44×10-12

1.23 (1.10-1.38)

2.17×10-4

1.29 (1.21-1.37)

2.23×10-15

rs8042680

PRC1

A

1.47 (1.37-1.58)

8.03×10-27

1.56 (1.39-1.75)

1.21×10-13

1.49 (1.41-1.59)

9.82×10-39

aMultiple testing was adjusted using Bonferroni correction
bResults from MESA and ARIC were combined using random-effects meta-analysis

Table 2: Significant associations of 12 GWAS-identified risk variants with prevalent T2D at enrollmenta.